sq-23377 and Varicose-Veins

sq-23377 has been researched along with Varicose-Veins* in 1 studies

Other Studies

1 other study(ies) available for sq-23377 and Varicose-Veins

ArticleYear
Short-term exposure to low concentrations of thapsigargin inhibits replication of cultured human vascular smooth muscle cells.
    The British journal of surgery, 1997, Volume: 84, Issue:3

    Central to the pathophysiology of stenosis following balloon angioplasty and arterial bypass surgery is proliferation of vascular smooth muscle cells (VSMCs). To investigate the role of calcium (Ca2+) in VSMC proliferation, the effect of thapsigargin, Ca2+ ionophore A23187, ionomycin, cyclopiazonic acid and di-tert-butylhydroquinone (all of which raise intracellular Ca2+ levels) on the proliferation of cultured human VSMCs was observed.. Cultured VSMCs from human saphenous vein were treated with calcium-modulating drugs and proliferation was assessed by determining [3H]thymidine and 5-bromo-2'-deoxyuridine incorporation and cell number.. Over a 48-h exposure, thapsigargin inhibited VSMC replication (median 50 per cent maximal inhibitory concentration 2 nmol/l) whereas the other drugs were much less effective. Short-term exposure (5, 10, 30 and 60 min) to thapsigargin elicited a significant dose-dependent inhibition of VSMC replication whereas, again, the other drugs were without significant effect.. Thapsigargin-sensitive intracellular Ca2+ pools play a key role in controlling VSMC proliferation and specialized means of administering thapsigargin may constitute a possible approach to preventing stenosis.

    Topics: Adult; Aged; Calcimycin; Calcium; Cell Division; Cells, Cultured; Enzyme Inhibitors; Female; Humans; Hydroquinones; Indoles; Ionomycin; Male; Middle Aged; Muscle, Smooth, Vascular; Saphenous Vein; Thapsigargin; Varicose Veins

1997